Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 28, 2024; 30(24): 3123-3125
Published online Jun 28, 2024. doi: 10.3748/wjg.v30.i24.3123
Published online Jun 28, 2024. doi: 10.3748/wjg.v30.i24.3123
Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritis
Bo-Tong Ma, Bing Chang, Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China
Li-Xuan Sang, Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110022, Liaoning Province, China
Author contributions: Ma BT wrote the original draft; Sang LX and Chang B revised the manuscript; and all authors have read and approved the final version of the manuscript.
Conflict-of-interest statement: There are no conflicts of interest to report.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bing Chang, MD, PhD, Chief Physician, Professor, Department of Gastroenterology, The First Affiliated Hospital of China Medical University, No. 155 Nanjing North Street, Shenyang 110001, Liaoning Province, China. cb000216@163.com
Received: April 27, 2024
Revised: May 27, 2024
Accepted: June 13, 2024
Published online: June 28, 2024
Processing time: 58 Days and 18.1 Hours
Revised: May 27, 2024
Accepted: June 13, 2024
Published online: June 28, 2024
Processing time: 58 Days and 18.1 Hours
Core Tip
Core Tip: The gastric microbiota is often related to the occurrence and development of many gastric diseases. Faecal microbiota transplantation has been used for treating immune checkpoint inhibitor (ICI)-associated colitis. Therefore, gastric microbiota transplantation is a promising treatment for ICI-associated gastritis.